JBS

JBS N.V. (JBS) Analyst Note Date: 2026-06-13 Analyst: StoryStocks-Native Equity Analyst

1. Structural Readiness

Technical Parameters:

• Conservative Entry: $17.88
• Current Price: $11.93
• Extension: -33.3% vs. conservative entry

Interpretation: The setup is no longer actionable as a long entry. The price extension of -33.3% indicates a significant deviation from the established structural entry point. The ATR at the time of the setup was 3.4% (productive), and the current ATR is 4.0% (productive), indicating that while volatility is within a manageable range for sizing, the structural integrity of the "Coil" has been breached. The setup is effectively closed for new long positions.

2. The Thesis Layer

Thesis Classification: TACTICAL / SETUP-LED Secular Exposure: None.

As of 2026-06-13, there is no named secular thesis attached to this specific setup. The investment case is not driven by a macro narrative (e.g., "global protein shortage" or "climate transition leader") but is strictly a function of the technical setup quality and the underlying business fundamentals.

Judgment Criteria: The name must be judged solely on:

• Setup Quality: Currently failed (Invalidated).
• Business Fundamentals: Strong operational performance in Q1 2026, despite management's cautious outlook for the full year.

Do not invent a macro thesis to justify the technical failure. The setup is invalid; the business remains a distinct entity with its own operational reality.

3. The Business

Company Profile: JBS N.V. is a leading global enterprise in the food and protein sector. As of the latest company profile cache (2026-06-12), the company operates through a vast network of subsidiaries worldwide, providing an extensive selection of food products including beef, pork, chicken, poultry, fish, and lamb, alongside prepared frozen meals and plant-based options.

Business Model & Operations: The company manages the full scope of leather production, treatment, and commercialization, in addition to manufacturing industrial materials such as steel cans, plastic resins, soap bases, biodiesel, glycerin, and various oleochemicals. The business model is vertically integrated, managing cattle fattening, warehousing, distribution centers, port logistics, and transportation services.

Operational Evidence (Source: Q1 2026 Earnings Transcript, 2026-05-13):

• Top Line: Net sales grew 11% year-over-year, reaching $21 billion, marking a record for the first quarter.
• Profitability: Total EBITDA was approximately $1.1 billion, representing a margin of 5.2%.
• Segment Performance:
• Seara (Brazil): Delivered an EBITDA margin of 15.5%, driven by strong export demand, innovation, and value-added products, despite currency pressure and cost inflation.
• JBS Brazil: Reported an EBITDA margin of 4.5%, noted as the second-highest first-quarter margin in history, supported by disciplined commercial execution.
• Australia: Margin reached 7.1%. Operational conditions in Queensland cattle were described as the best seen in the last three years.
• Poultry (Brazil): Outlook remained positive, supported by supply-demand balancing and continuous demand growth.
• Sustainability: The company is on track to meet its Global Greenhouse Gas Emissions Intensity reduction target of 20.30% by December 31, 2026 (from a 2019 baseline), as per the Sustainability-Linked Bond Framework filed on 2026-03-25.

Financial Outlook (Management Expectations): Management explicitly stated on 2026-05-13 that "2026 will be a more challenging year than 2025." They expect Q2 to be better than Q1, but the full-year outlook is tempered. Management provided a cash flow breakeven EBITDA target between $5.7 billion and $6.0 billion for the year.

4. Archetype and Conviction

Archetype: Defensive Operator Rationale: The name fits the "Defensive Operator" archetype due to its diversified portfolio (beef, pork, poultry, leather, industrial by-products) and its ability to generate record sales and margins in specific segments (Seara, Australia) even amidst "challenging" macro conditions. The business model is capital intensive but generates significant cash flow, evidenced by the $1.1B Q1 EBITDA.

Conviction Stack:

• Thesis Strength: Low (No named secular thesis; purely tactical).
• Evidence Quality: High. The earnings transcript provides granular, positive data on margins and volume growth across key regions.
• Structural Quality: Mixed. While the business fundamentals are strong (record sales, high margins in key segments), the technical structure is broken.
• Rerating Potential: Unclear. While management expects Q2 to improve, the explicit warning that 2026 is "more challenging" than 2025 suggests limited immediate multiple expansion.

ATR Context:

• ATR at Breakout: 3.4% (Productive).
• Current ATR: 4.0% (Productive).

5. Invalidating / Strengthening Factors & Gaps

What Would Invalidate the Case Further:

• Management lowering the full-year EBITDA guidance below the $5.7B–$6.0B range.
• Deterioration in the "best in 3 years" cattle conditions in Australia or a reversal in the positive poultry outlook in Brazil.

What Would Strengthen the Case:

• A confirmed breakout above the $17.88 conservative entry level (requiring a massive move from current levels).
• Q2 earnings significantly exceeding the "better than Q1" expectation, with EBITDA margins expanding beyond the 5.2% Q1 level.
• A clear signal that the "challenging" nature of 2026 is resolving faster than anticipated, allowing the company to exceed the $6.0B breakeven target.

Evidence Gaps:

• Missing Evidence: There is no specific data on the *current* (June 2026) inventory levels or the specific impact of the "currency pressure" mentioned in Q1 on the current quarter's margins.
• Missing Evidence: No specific guidance on the *timing* of the "better than Q1" performance beyond the general Q2 expectation.
• Missing Evidence: No data on the specific capital expenditure (Capex) plans for the remainder of 2026, which could impact free cash flow given the "challenging" outlook.

PRIVATE ANALYST CALL

Judgment: Sell Confidence: high Key risks: Potential for further downside if Q2 results fail to meet "better than Q1" expectations; currency headwinds impacting Seara and Brazil margins; lack of a named secular thesis to support a rerating. Sizing hint: Position size should be zero for new longs; existing positions should be exited or hedged. Expected path: Price likely to remain range-bound or drift lower until a new structural support level is established or management provides a revised, more optimistic outlook for the remainder of 2026. Expected horizon: Indefinite until structural invalidation is resolved or a new setup forms.